Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 11, 1996, Pages 933-935

  Rosenblatt, Karin A ^a,c   Thomas, David B ^b,c  

^a Department of Community Health ^*  (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLEAR CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; PARITY; PRIORITY JOURNAL; UTERINE TUBE LIGATION;

CANCER; CASE CONTROL STUDIES; DISEASES; FAMILY PLANNING; FEMALE STERILIZATION; GYNECOLOGIC SURGERY; HYSTERECTOMY; NEOPLASMS; OVARIAN CANCER; RESEARCH METHODOLOGY; RESEARCH REPORT; STERILIZATION, SEXUAL; STUDIES; SURGERY; TREATMENT; TUBAL LIGATION--BENEFICIAL EFFECTS; TUBAL OCCLUSION; UROGENITAL SURGERY;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; OVARIAN NEOPLASMS; PARITY; RISK FACTORS; STERILIZATION, TUBAL;

EID: 0029844126     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hankinson, S. E., Hunter, D. J., Colditz, G. A., Willett, W. C., Stampfer, M. J., Rosner, B., Hennekens, C. H., and Speizer, F. E. Tubal ligation, hysterectomy, and risk of ovarian cancer: a prospective study. JAMA, 270: 2813-2818, 1993.
2. Irwin, K. L., Weiss, N. S., Lee, N. C., and Peterson, H. B. Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am. J. Epidemiol., 134: 362-369, 1991.
3. Whittemore, A. S., Wu, M. L., Paffenbarger, R. S., Sarles, D. L., Kampert, J. B., Grosser, S., Jung, D. L., Ballon, S., and Hendrickson, M. Personal and environmental characteristics related to epithelial ovarian cancer. Am. J. Epidemiol., 128: 1228-1240, 1988.
4. Whittemore, A. S., Harris, R., Itnyre, J., and the Collaborative Ovarian Cancer Group. Characteristics relative to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am. J. Epidemiol., 136: 1184-1203, 1992.
5. Booth, M., Beral, V., and Smith, P. Risk factors for ovarian cancer: a case-control study. Br. J. Cancer 60: 592-598, 1989.
6. Rosenblatt, K. A., Szklo, M., and Rosenshein, N. B. Mineral fiber exposure and the development of ovarian cancer. Gynecol. Oncol., 45: 20-25, 1992.
7. Mon, M., Harabuchi, I., Miyake, H., Casagrande, J. T., Henderson, B. E., and Ross, R. K. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am. J. Epidemiol., 128: 771-777, 1988.
8. Cramer, D. W., and Xu, H. Epidemiologic evidence of uterine growth factors in the pathogenesis of ovarian cancer. Ann. Epidemiol., 5: 310-314, 1995.
9. Shu, X. O., Brinton, L. A., Gao, Y. T., and Yuan, J. M. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res., 49: 3670-3674, 1989.
10. Koch, M., Starreveld, A. A., Hill, G. B., and Jenkins, H. The effect of tubal ligation on the incidence of epithelial cancer of the ovary. Cancer Detect. Prev., 7: 241-245, 1984.
11. Annegers, J. F., Strom, H., Decker, D. G., Dockerty, M. B., and O'Fallon, M. Ovarian cancer: incidence and case-control study. Cancer (Phila.) 43: 723-729, 1979.
12. McGowan, L., Parent, L., Lednar, W., and Norris, H. J. The woman at risk for developing ovarian cancer. Gynecol. Oncol., 7: 325-344, 1979.
13. Parazzini, F., Negri, E., La Vecchia, C., Luchini, L., and Mezzopane, R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet. Gynecol., 81: 363-366, 1993.
14. Weiss, N. S., and Harlow, B. L. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer. Am. J. Epidemiol., 124: 856-858, 1986.
15. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives. Int. J. Epidemiol., 18: 538-545, 1989.
16. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32. Lyon: France: IARC, 1980.
17. Hirji, K. F., Mehta, C. R., and Patel, N. R. Exact inference for matched case-control studies. Biometrics, 44: 803-814, 1988.
18. Hange, P., Hoover, R., McGowan, L., Lesher, L., and Norris, H. J. Menopause and ovarian cancer. Am. J. Epidemiol., 127: 990-998, 1988.
19. Weiss, N. S., Lyon, J. L., Krishnamurthy, S., Dietert, S. E., Liff, J. M., and Daling, J. R. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J. Natl. Cancer Inst., 68: 95-98, 1982.
20. La Vecchia, C., Liberati, A., and Franceschi, S. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J. Natl. Cancer Inst., 69: 1207, 1982.
21. Cramer, D. W., Devesa, S. S., and Welch, W. R. Trends in the incidence of endometrioid and clear cell cancers of the ovary in the United States. Am. J. Epidemiol., 114: 201-208, 1981.
22. Corson, S. L., Levinson, C. J., Batzer, F. R., and Otis, C. Hormonal levels following sterilization and hysterectomy. J. Reprod. Med., 26: 363-370, 1981.
23. Radwanska, E., Headley, S. K., and Dmowki, P. Evaluation of ovarian function after tubal sterilization. J. Reprod. Med., 27: 376-384, 1982.
24. Stone, D. C., Dickey, R. P., and Mickal, A. The acute effect of hysterectomy on ovarian function. Am. J. Obstet. Gynecol., 121: 193-197, 1977.
25. Janson, P. O., and Jansson, I. The acute effect of hysterectomy on ovarian blood now. Am. J. Obstet. Gynecol., 127: 349-352, 1977.
26. Cattanach, J. Oestrogen deficiency after tubal ligation. Lancet, 1: 847-849, 1985.